Vertex and NHS England Set Date For Next Round Of Orkambi Pricing Talks
Vertex and NHS England are to resume talks next week over pricing of cystic fibrosis drug Orkambi.
You may also be interested in...
Pressure Rises On Vertex and NHS England To Reach Orkambi Deal As Parliamentary Scrutiny Increases
Vertex and NHS England are under pressure to strike a deal on cystic fibrosis drug Orkambi after UK a parliamentary debate put health technology appraisal body NICE under the spotlight.
Vertex Commits To Novel Reimbursement Plan For Orkambi In UK, Despite Setback
Despite an initial rejection from NHS England, Vertex remains committed to bringing its novel reimbursement plan to England to secure access to its cystic fibrosis drug, Orkambi.
Novo Nordisk Hit With UK Industry Association Suspension Over Weight Loss Drug Promotion
Novo Nordisk has been hit by a serious sanction in the UK after having been found to effectively pay pharmacists to promote Saxenda.